AUPH Aurinia Pharmaceuticals

Watchlist

8.160
+0.050+0.62%

Close Mar 14 16:00 ET

8.370
+0.210+2.57%

Post 20:01 ET

1.12BMarket Cap204.00P/E (TTM)

About Aurinia Pharmaceuticals Company

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Company Profile

SymbolAUPH

Company NameAurinia Pharmaceuticals

Listing DateFeb 25, 2000

Founded1993

CEOMr. Peter S. Greenleaf

MarketNASDAQ

Employees130

Fiscal Year Ends12-31

Address14315 – 118 Avenue,Suite 140

CityEdmonton

ProvinceAlberta

CountryCanada

Zip CodeT5L 4S6

Phone1-250-744-2487

Websitehttp://www.auriniapharma.com

Company Executives

Name
Position
Salary

Peter S. Greenleaf
President, Chief Executive Officer and Director
10.57M

Joseph M. Miller
Chief Financial Officer and Principal Accounting Officer
3.98M

Stephen P. Robertson
Executive Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer
3.60M

Matthew Donley
Executive Vice President, Operations and Strategy
4.56M

Craig A. Johnson
Director
--

Kevin C. Tang
Director
--

Jill D. Leversage
Independent Director
267.28K

Dr. Karen L. Smith, L.L.M.,M.B.A.,M.D.,PhD
Independent Director
359.41K

Dr. David R.W. Jayne, F.R.C.P.,M.D.
Independent Director
249.92K

Jeffrey Allen Bailey
Independent Director
361.51K

AUPH Aurinia Pharmaceuticals

About Aurinia Pharmaceuticals Company

Company Profile

Company Executives

Trending Stocks